A PoTENtial Antidote: A Prohemostatic Factor Xa Variant for Reversal of Direct Oral Anticoagulants

Circ Res. 2016 Nov 11;119(11):1157-1160. doi: 10.1161/CIRCRESAHA.116.309820.
No abstract available

Publication types

  • Comment

MeSH terms

  • Administration, Oral
  • Anticoagulants
  • Antidotes*
  • Factor Xa*
  • Hemorrhage
  • Humans
  • Recombinant Proteins

Substances

  • Anticoagulants
  • Antidotes
  • Recombinant Proteins
  • Factor Xa